CompanyIntelligence | Novuspharma

The Consus Group provides critical intelligence for the
business, investor, and legal communities.

Documents can be downloaded immediately after purchase. Complete your order by clicking the Add-to-Cart button.

$85	Subscribers Preview	2003	Agreement and Plan of Merger	CTI; Novuspharma	Skadden; WSGR
$65	Subscribers Preview	2003	Agreement and Plan of Merger	CTI; Novuspharma	Skadden; WSGR
$99	Subscribers Preview	2003	Agreement and Plan of Merger	Novuspharma
$34	Subscribers	2003	Cell Therapeutics, Inc. (Cti) Adds Pixantrone to Its Oncology Drug Pipeline and Extends Global Cancer Business Through Merger with Novuspharma S.p.A.	CTI; Novuspharma	CIBC World
$35	Subscribers	2003	Cell Therapeutics, Inc. (CTI) Adds Pixantrone to Its Oncology Drug Pipeline and Extends Global Cancer Business Through Merger with Novuspharma S.p.A.	CTI; Novuspharma	CIBC World
$40	Subscribers	2004	Cell Therapeutics, Inc. (CTI) and Novuspharma S.p.A. Complete Merger	Cell Therapeutics, Inc.	Novuspharma
$34	Subscribers	2004	Cell Therapeutics, Inc. (CTI) Announces First Quarter 2004 Financial Results	Cell Therapeutics, Inc.	Novuspharma
$39	Subscribers	2003	Cell Therapeutics, Inc. and Novuspharma S.p.A. Announce Shareholder Approval of Merger	Cell Therapeutics, Inc.	Novuspharma
$40	Subscribers	2003	Cell Therapeutics, Inc. Announces Borsa Italiana Approval of Listing of Shares on Nuovo Mercato	Cell Therapeutics, Inc.	Novuspharma
$35	Subscribers	2003	Cell Therapeutics, Inc. Second Quarter Revenues More Than Double Over Same Period in 2002	Cell Therapeutics, Inc.	Novuspharma
$35	Subscribers	2003	Cell Therapeutics, Inc. Second Quarter Revenues More Than Double Over Same Period in 2002	Cell Therapeutics, Inc.	Novuspharma
$33	Subscribers	2004	CTI Reports Quarterly & Year End Results	Cell Therapeutics, Inc.	Novuspharma
$37	Subscribers Preview	2003	Employment Agreement	Cesare Parachini; CTI	Novuspharma
$35	Subscribers Preview	2003	Employment Agreement	Cell Therapeutics, Inc.	Novuspharma
$35	Subscribers Preview	2003	Employment Agreement	Cell Therapeutics, Inc.	Novuspharma
$35	Subscribers Preview	2003	Employment Agreement	Cell Therapeutics, Inc.	Novuspharma
$52	Subscribers Preview	2003	Indenture	CTI; Novuspharma; CIBC World	Nasdaq Stock Market Inc. 2 3
$70	Subscribers Preview	2003	Indenture	CTI; Novuspharma; CIBC World	Nasdaq Stock Market Inc. 2 3
$31	Subscribers	2004	KPMG S.p.A. Says It Was Not Independent with Respect to Novuspharma S.p.A.	Cell Therapeutics, Inc.	Novuspharma
$35	Subscribers	2003	Merger of Novuspharma S.p.A. in Cell Therapeutics, Inc.	Cell Therapeutics, Inc.	Novuspharma